De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody

Journal of Infectious Diseases

Volumn 187, Issue 8, 2003, Pages 1323-1326

  Lu, Mengji ^a   Lorentz, Thomas ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HEPATITIS B SURFACE ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CASE REPORT; CELL CULTURE; CULTURE MEDIUM; CYTOTOXIC T LYMPHOCYTE; EXPRESSION VECTOR; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; KIDNEY TRANSPLANTATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RECIPIENT;

ADULT; ANIMALS; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MICE; MUTATION;

EID: 0037447282     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/373902     Document Type: Article

References (15)

1. Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1981; 1:377-85.
2. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 1997; 4(Suppl 1):11-20.
3. Cooreman MP, Leroux-Roels G, Paulij WP. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 2001; 8:237-47.
4. Carman WF, Trautwein C, Van Deursen FJ, et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 1996; 24:489-93.
5. Karthigesu VD, Allison LM, Fortuin M, Mendy M, Whittle HC, Howard CR. A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 1994; 75:443-8.
6. Carman WF, Van Deursen FJ, Mimms LT, et al. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 1997; 26:1658-66.
7. Weinberger KM, Bauer T, Böhm S, Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen HBsAg and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000; 81:1165-74.
8. Yoshida EM, Ramji A, Erb SR, et al. De novo acute hepatitis B infection in a previously vaccinated liver transplant recipient due to a strain of HBV with a Met 133 Thr mutation in the "a" determinant. Liver 2000; 20:411-4.
9. Schirmbeck R, Zheng X, Roggendorf M, et al. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen. J Immunol 2001; 166:1405-13.
10. Zheng X, Schirmbeck R, Hilken G, et al. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization. Virology 2002; 294:342-53.
11. Norder H, Hammas B, Lee SD, et al. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 1993; 74:1341-8.
12. Okamoto H, Imai M, Miyakawa Y, Mayumi M. Site-directed muta-genesis of hepatitis B surface antigen sequence at codon 160 from arginine to lysine for conversion of subtypic determinant from r to w. Biochem Biophys Res Commun 1987; 148:500-4.
13. Gunther S, Fischer L, Pult I, Sterneck M, Will H. Naturally occurring variants of hepatitis B virus. Adv Virus Res 1999; 52:25-137.
14. Okamoto H, Omi S, Wang Y, et al. The loss of subtypic determinants in alleles, d/y or w/r, on hepatitis B surface antigen. Mol Immunol 1989; 26:197-205.
15. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13:29-60.